Lyra Therapeutics, Inc.

Q4 2021 13F Holders

Symbol: LYRA
CUSIP: 55234L105
Type: Equity
Class: COM
Num filings: 37
Total reported value, excl. options: $36.5 M

Compare 2021 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type